Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 779Lung Neoplasms 345Ovarian Neoplasms 323Breast Neoplasms 279Fallopian Tube Neoplasms 159Triple Negative Breast Neoplasms 145Small Cell Lung Carcinoma 144Neoplasms 137Squamous Cell Carcinoma of Head and Neck 123Carcinoma, Ovarian Epithelial 114Neoplasm Metastasis 85Head and Neck Neoplasms 80Endometrial Neoplasms 76Uterine Cervical Neoplasms 72Esophageal Neoplasms 71Adenocarcinoma of Lung 70Neuroblastoma 55Central Nervous System Neoplasms 53Lymphoma, Large B-Cell, Diffuse 49Carcinoma 49Recurrence 48Brain Neoplasms 48Prostatic Neoplasms 44Parkinson Disease 4, Autosomal Dominant Lewy Body 44Urinary Bladder Neoplasms 42Esophageal Squamous Cell Carcinoma 41Lymphoma 39Melanoma 35Carcinoma, Squamous Cell 33Stomach Neoplasms 31

Interventions

Resistance Training 6Exercise 5Ultrasonography 3Docosahexaenoic Acids 3maltodextrin 2Walking Speed 2Tomography, X-Ray Computed 2Nutrition Assessment 2Hand Strength 2Gastrectomy 2Esophagectomy 2Drug Therapy 2pembrolizumab 1nicotinamide-beta-riboside 1fucoidan 1durvalumab 1atezolizumab 1Whey Proteins 1Wearable Electronic Devices 1Testosterone 1Standard of Care 1Soybean Proteins 1Relaxation Therapy 1Preoperative Exercise 1Olive Oil 1Nutritional Status 1Nutrition Therapy 1Nivolumab 1Immunotherapy 1Immune Checkpoint Inhibitors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Sarcopenia × Carboplatin × Clear all
NCT02734069 2025-12-24

Impact of Fat-free Mass in the Carboplatin Calculated Dose and Chemotherapeutic Toxicity in Patients With Advanced NSCLC

Instituto Nacional de Cancerologia de Mexico

Recruiting
132 enrolled
Thoracic

Lung Neoplasms, Sarcopenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡